Craig C. Hopkinson - Feb 16, 2022 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
EVP R&D, Chief Medical Officer
Signature
/s/ Stephanie Roche, attorney-in-fact for Craig C. Hopkinson
Stock symbol
ALKS
Transactions as of
Feb 16, 2022
Transactions value $
-$28,639
Form type
4
Date filed
2/17/2022, 03:24 PM
Previous filing
Sep 16, 2021
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Options Exercise +3.38K +35.54% 12.9K Feb 16, 2022 Direct F1
transaction ALKS Ordinary Shares Tax liability -$28.6K -1.07K -8.31% $26.79 11.8K Feb 16, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKS Restricted Stock Unit Award Options Exercise -3.38K -100% 0 Feb 16, 2022 Ordinary Shares 3.38K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into ordinary shares on a one-for-one basis.
F2 This award is fully vested in accordance with its terms.